CN106726972A - 一种沙棘组合物及应用和由其制备形成的护肤膏和该护肤膏的制备方法 - Google Patents
一种沙棘组合物及应用和由其制备形成的护肤膏和该护肤膏的制备方法 Download PDFInfo
- Publication number
- CN106726972A CN106726972A CN201611227837.5A CN201611227837A CN106726972A CN 106726972 A CN106726972 A CN 106726972A CN 201611227837 A CN201611227837 A CN 201611227837A CN 106726972 A CN106726972 A CN 106726972A
- Authority
- CN
- China
- Prior art keywords
- parts
- hippophae rhamnoides
- cold cream
- skin
- borneol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000003145 Hippophae rhamnoides Nutrition 0.000 title claims abstract description 43
- 240000000950 Hippophae rhamnoides Species 0.000 title claims abstract description 40
- 239000000203 mixture Substances 0.000 title claims abstract description 36
- 239000008294 cold cream Substances 0.000 title claims abstract description 34
- 238000002360 preparation method Methods 0.000 title claims abstract description 17
- UILPJVPSNHJFIK-UHFFFAOYSA-N Paeonol Chemical compound COC1=CC=C(C(C)=O)C(O)=C1 UILPJVPSNHJFIK-UHFFFAOYSA-N 0.000 claims abstract description 34
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 27
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 26
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 claims abstract description 26
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 claims abstract description 26
- 229940116229 borneol Drugs 0.000 claims abstract description 26
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 claims abstract description 26
- 239000000284 extract Substances 0.000 claims abstract description 26
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 claims abstract description 21
- 241000723346 Cinnamomum camphora Species 0.000 claims abstract description 21
- 229930008380 camphor Natural products 0.000 claims abstract description 21
- 229960000846 camphor Drugs 0.000 claims abstract description 21
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 claims abstract description 20
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 claims abstract description 20
- 229940041616 menthol Drugs 0.000 claims abstract description 20
- 230000002087 whitening effect Effects 0.000 claims abstract description 20
- YLTGFGDODHXMFB-UHFFFAOYSA-N isoacetovanillon Natural products COC1=CC=C(C(C)=O)C=C1O YLTGFGDODHXMFB-UHFFFAOYSA-N 0.000 claims abstract description 17
- MLIBGOFSXXWRIY-UHFFFAOYSA-N paeonol Natural products COC1=CC=C(O)C(C(C)=O)=C1 MLIBGOFSXXWRIY-UHFFFAOYSA-N 0.000 claims abstract description 17
- 230000003712 anti-aging effect Effects 0.000 claims abstract description 16
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 14
- 239000003963 antioxidant agent Substances 0.000 claims abstract description 9
- 230000003078 antioxidant effect Effects 0.000 claims abstract description 9
- 239000003974 emollient agent Substances 0.000 claims abstract description 9
- 230000000149 penetrating effect Effects 0.000 claims abstract description 9
- 239000002562 thickening agent Substances 0.000 claims abstract description 8
- 239000006097 ultraviolet radiation absorber Substances 0.000 claims abstract description 8
- GQEZCXVZFLOKMC-UHFFFAOYSA-N n-alpha-hexadecene Natural products CCCCCCCCCCCCCCC=C GQEZCXVZFLOKMC-UHFFFAOYSA-N 0.000 claims description 20
- 239000000463 material Substances 0.000 claims description 19
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 18
- 238000001816 cooling Methods 0.000 claims description 16
- 238000003756 stirring Methods 0.000 claims description 16
- 229920002367 Polyisobutene Polymers 0.000 claims description 15
- AXTGDCSMTYGJND-UHFFFAOYSA-N 1-dodecylazepan-2-one Chemical group CCCCCCCCCCCCN1CCCCCC1=O AXTGDCSMTYGJND-UHFFFAOYSA-N 0.000 claims description 14
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 claims description 14
- 229960003639 laurocapram Drugs 0.000 claims description 14
- 238000000034 method Methods 0.000 claims description 14
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 claims description 14
- 229960001679 octinoxate Drugs 0.000 claims description 14
- 229930003799 tocopherol Natural products 0.000 claims description 14
- 229960001295 tocopherol Drugs 0.000 claims description 14
- 239000011732 tocopherol Substances 0.000 claims description 14
- 235000010384 tocopherol Nutrition 0.000 claims description 14
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 claims description 13
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims description 12
- 229920001577 copolymer Polymers 0.000 claims description 11
- -1 gaultherolin Chemical compound 0.000 claims description 11
- 238000001914 filtration Methods 0.000 claims description 9
- 239000004744 fabric Substances 0.000 claims description 8
- 230000008569 process Effects 0.000 claims description 5
- 238000012360 testing method Methods 0.000 claims description 5
- 238000009472 formulation Methods 0.000 claims description 3
- 238000005303 weighing Methods 0.000 claims description 3
- 239000000839 emulsion Substances 0.000 claims description 2
- 229940098465 tincture Drugs 0.000 claims description 2
- 125000002640 tocopherol group Chemical group 0.000 claims description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims 2
- 239000006071 cream Substances 0.000 claims 1
- 150000002148 esters Chemical class 0.000 claims 1
- 235000011187 glycerol Nutrition 0.000 claims 1
- 239000004033 plastic Substances 0.000 claims 1
- 229920003023 plastic Polymers 0.000 claims 1
- 125000000383 tetramethylene group Chemical group [H]C([H])([*:1])C([H])([H])C([H])([H])C([H])([H])[*:2] 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 15
- 239000002537 cosmetic Substances 0.000 abstract description 8
- 239000002994 raw material Substances 0.000 abstract description 7
- 206010053615 Thermal burn Diseases 0.000 abstract description 2
- 238000010521 absorption reaction Methods 0.000 abstract description 2
- 238000001764 infiltration Methods 0.000 abstract description 2
- 230000008595 infiltration Effects 0.000 abstract description 2
- 230000001105 regulatory effect Effects 0.000 abstract description 2
- 230000009759 skin aging Effects 0.000 abstract description 2
- 210000003491 skin Anatomy 0.000 description 37
- 235000019198 oils Nutrition 0.000 description 26
- 230000000052 comparative effect Effects 0.000 description 18
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 14
- 239000000047 product Substances 0.000 description 11
- 239000001993 wax Substances 0.000 description 11
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 235000006708 antioxidants Nutrition 0.000 description 5
- 238000007334 copolymerization reaction Methods 0.000 description 5
- 244000157790 Buglossoides arvense Species 0.000 description 4
- 235000004256 Buglossoides arvense Nutrition 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 239000008188 pellet Substances 0.000 description 4
- 239000000049 pigment Substances 0.000 description 4
- 231100000614 poison Toxicity 0.000 description 4
- 241000229143 Hippophae Species 0.000 description 3
- 208000002193 Pain Diseases 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 230000001139 anti-pruritic effect Effects 0.000 description 3
- 230000019522 cellular metabolic process Effects 0.000 description 3
- 230000001815 facial effect Effects 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 230000036564 melanin content Effects 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 230000036407 pain Effects 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 235000015112 vegetable and seed oil Nutrition 0.000 description 3
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 102000019197 Superoxide Dismutase Human genes 0.000 description 2
- 108010012715 Superoxide dismutase Proteins 0.000 description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 239000011149 active material Substances 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 208000026935 allergic disease Diseases 0.000 description 2
- 230000007815 allergy Effects 0.000 description 2
- 239000003908 antipruritic agent Substances 0.000 description 2
- 238000005842 biochemical reaction Methods 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 210000002752 melanocyte Anatomy 0.000 description 2
- 230000004089 microcirculation Effects 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- SECPZKHBENQXJG-FPLPWBNLSA-N palmitoleic acid Chemical compound CCCCCC\C=C/CCCCCCCC(O)=O SECPZKHBENQXJG-FPLPWBNLSA-N 0.000 description 2
- 210000003800 pharynx Anatomy 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 231100000241 scar Toxicity 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 239000012178 vegetable wax Substances 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 229940045997 vitamin a Drugs 0.000 description 2
- 239000003643 water by type Substances 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- 150000005208 1,4-dihydroxybenzenes Chemical class 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- NEZONWMXZKDMKF-JTQLQIEISA-N Alkannin Chemical class C1=CC(O)=C2C(=O)C([C@@H](O)CC=C(C)C)=CC(=O)C2=C1O NEZONWMXZKDMKF-JTQLQIEISA-N 0.000 description 1
- 241001116389 Aloe Species 0.000 description 1
- 208000037259 Amyloid Plaque Diseases 0.000 description 1
- 241000205585 Aquilegia canadensis Species 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 241001647745 Banksia Species 0.000 description 1
- 241001313857 Bletilla striata Species 0.000 description 1
- 241000233838 Commelina Species 0.000 description 1
- 244000301850 Cupressus sempervirens Species 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 206010014080 Ecchymosis Diseases 0.000 description 1
- 244000286838 Eclipta prostrata Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010021135 Hypovitaminosis Diseases 0.000 description 1
- 201000008197 Laryngitis Diseases 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 244000269152 Myrica pensylvanica Species 0.000 description 1
- 235000012851 Myrica pensylvanica Nutrition 0.000 description 1
- 241000475481 Nebula Species 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 235000021319 Palmitoleic acid Nutrition 0.000 description 1
- 241000404144 Pieris melete Species 0.000 description 1
- 208000012641 Pigmentation disease Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 101710147108 Tyrosinase inhibitor Proteins 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000001760 anti-analgesic effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 229940105847 calamine Drugs 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 150000001765 catechin Chemical class 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- SECPZKHBENQXJG-UHFFFAOYSA-N cis-palmitoleic acid Natural products CCCCCCC=CCCCCCCCC(O)=O SECPZKHBENQXJG-UHFFFAOYSA-N 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000010612 desalination reaction Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 210000001339 epidermal cell Anatomy 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 229910052864 hemimorphite Inorganic materials 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 230000000622 irritating effect Effects 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 230000003780 keratinization Effects 0.000 description 1
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 1
- 229960004705 kojic acid Drugs 0.000 description 1
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000008338 local blood flow Effects 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 239000012982 microporous membrane Substances 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 230000037311 normal skin Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 238000010422 painting Methods 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 239000003507 refrigerant Substances 0.000 description 1
- 238000011076 safety test Methods 0.000 description 1
- 238000009781 safety test method Methods 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- 239000002884 skin cream Substances 0.000 description 1
- 230000005808 skin problem Effects 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 231100000041 toxicology testing Toxicity 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 235000014692 zinc oxide Nutrition 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- CPYIZQLXMGRKSW-UHFFFAOYSA-N zinc;iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+3].[Fe+3].[Zn+2] CPYIZQLXMGRKSW-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
- A61K31/125—Camphor; Nuclear substituted derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/618—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/30—Boraginaceae (Borage family), e.g. comfrey, lungwort or forget-me-not
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/35—Ketones, e.g. benzophenone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Birds (AREA)
- Mycology (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Emergency Medicine (AREA)
- Microbiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Inorganic Chemistry (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicines Containing Plant Substances (AREA)
- Cosmetics (AREA)
Abstract
本发明提供了一种具有美白抗衰老功效的沙棘组合物,包括沙棘果油、紫草提取物、水杨酸甲酯、薄荷脑、樟脑、丹皮酚和冰片。并进一步的提供了该组合物制备形成护肤膏,其是在上述原料的基础上增加润肤剂、增稠剂、促渗剂、抗氧化剂和紫外线吸收剂中的一种或几种制备形成。本申请的组合物主次兼修、综合调理皮肤,使各个指标都能恢复健康,起到防止皮肤老化、淡斑的作用,还可以用于治疗烧杀和烫伤。由其制备形成的护肤膏,能有效促进皮肤对上述组合物的渗透和吸收,使其更好的发挥护肤作用,同时调节化妆品的性状,易于保存和涂覆。
Description
技术领域
本发明涉及组合物技术领域,具体涉及一种具有美白抗衰老功效的沙棘组合物及其应用,同时涉及由该组合物制备形成的护肤品,以及该护肤品的制备方法。
背景技术
化妆品既是日常生活的必需品,又是顺应时代潮流的消费品,随着科学技术的发展,化妆品的内在、外在形式不断的更新,使用的原料也不断地推陈出新,各种新型的、高效的、功能的、生物的、天然的、温和的原料层出不穷,新型的化妆品不断涌现,在人们生活中的位置也越来越重要。
化妆品的功能性是业内人士与消费者追求的目标,例如美白、保湿、袪斑、抗衰老、抗皱、抗敏等等,纵观目前的化妆品市场,虽然产品众多,但功能单一,例如,传统的美白霜其美白机理大概分为两种,其一是黑色素还原机理,如维生素C美白,但美白效果不持久,显浮于表面,其二是通过阻断黑素细胞内发生的生化反应过程,抑制黑色素的生成而达到美白效果,其从根本上解决了皮肤色素沉积的问题,阻断产生黑色素的发生链。利用这一机理的活性物质主要是酪氨酸酶抑制剂,常见的有氢醌、曲酸、熊果素、对苯二酚等物质,但这些物质的活性低、细胞毒性高、穿透能力弱,可能引起一系列的健康隐患,如不可逆的皮损、黄褐斑、黑素退化等。虽然起到美白的效果,却给肌肤带来另一重不可预见的更加严重的问题,脱离了护肤的初衷。
因此,如何能够在美白的同时,还能有效的解决或预防其他的问题,赋予其多重功效,成为真正意义上的护肤产品,是相关研究人员面临的巨大挑战。
发明内容
因此,本发明要解决的技术问题在于克服现有技术中的化妆品功效单一且具有副作用的缺陷,从而提供一种兼具美白和抗衰老功效于一体的组合物,及由其制备形成的护肤膏,以及该护肤膏的制备方法。
为此,本申请采取的技术方案为,
一种具有美白抗衰老功效的沙棘组合物,包括如下重量份的组分,
沙棘果油20-30份;
紫草提取物20-25份;
水杨酸甲酯3.5-4.5份;
薄荷脑1.5-2.5份;
樟脑1.5-2.5份;
丹皮酚0.5-1.5份;
冰片0.5-1.5份。
优选地,上述具有美白抗衰老功效的沙棘组合物,包括如下重量份的组分,
沙棘果油25份;
紫草提取物23份;
水杨酸甲酯4份;
薄荷脑2份;
樟脑2份;
丹皮酚1份;
冰片1份。
优选地,上述具有美白抗衰老功效的沙棘组合物,以常规工艺制备形成可以接受的剂型。
优选地,上述具有美白抗衰老功效的沙棘组合物,所述剂型为外用油剂、膏剂、涂膜剂、酊剂、凝胶剂、霜或乳液。
一种上述任一所述的具有美白抗衰老功效的沙棘组合物制备形成的护肤膏,还包括润肤剂、增稠剂、促渗剂、抗氧化剂和紫外线吸收剂中的一种或几种。
优选地,上述护肤膏中,所述润肤剂为15-25份辛酸/癸酸甘油三酯;所述增稠剂选自聚异丁烯、VP/十六碳烯共聚物和小烛树蜡中的一种或几种,其中聚异丁烯8-12份、VP/十六碳烯共聚物4-5份、小烛树蜡2.5-3.5份;所述促渗剂为月桂氮卓酮0.1-0.8份;抗氧化剂为生育酚2.5-3.5份,紫外线吸收剂甲氧基肉桂酸乙基己酯0.5-1.5份。
优选地,上述护肤膏,还包括,
辛酸/癸酸甘油三酯20份;
聚异丁烯10份、
VP/十六碳烯共聚物4.5份、
小烛树蜡3份;
月桂氮卓酮0.5份;
生育酚3份;
甲氧基肉桂酸乙基己酯1份。
一种制备上述任一护肤膏的方法,包括,
(1)称取所需重量份的丹皮酚、樟脑、薄荷脑、水杨酸甲酯、冰片和抗氧剂混合形成B料,备用;
(2)称取所需重量份的沙棘果油、紫草提取物、润肤剂、增稠剂、促渗剂和紫外线吸收剂混合形成A料,加热至85℃,并保温搅拌使A料完全溶解后,开始降温,待温度降至65℃时加入所述B料,并搅拌至完全溶解后,继续搅拌降温;
(3)待降温至35℃以下时,200目滤布过滤得到滤渣,熟化制得所需的护肤膏。
上述制备护肤膏的方法中,所述步骤(3)中还包括待降温至35℃以下时,先进行检验,待检验合格后再进行过滤的步骤。
上述任一所述的具有美白抗衰老功效的沙棘组合物的应用。
本发明技术方案,具有如下优点:
1、本发明提供的一种具有美白抗衰老功效的沙棘组合物,包括特定重量份的沙棘果油、紫草提取物、水杨酸甲酯、薄荷脑、樟脑、丹皮酚和冰片。
沙棘果油是由棕榈酸、棕榈烯酸、硬脂酸、油酸、亚油酸、亚麻酸等多种有益脂肪酸组成,其中不饱和脂肪酸高达70%,沙棘果油中类胡萝卜素和维生素E以及多种微量元素如人体不可缺少的维生素A、硒、镁、锌、铁、锰等含量亦较高。沙棘中的少量植物甾醇、儿茶素类、黄酮类化合物,在制油的过程中也富集于沙棘果油,这些活性物质多为人体细胞组成和维持生命活动不可缺少的物质,参与机体的生命活动的各个环节。此外,沙棘果油中的生育酚对皮肤有保护作用,保护细胞膜中的不饱和脂肪酸在光、热和辐射条件下不被氧化,以防止变态、发皱及脂褐质的堆积并能改善微循环。其具有降低动物体内过氧化脂质作用,其效果较维生素E更显著。β胡萝卜素可以通过皮肤直接进入表皮细胞并转化为维生素A而营养皮肤,以避免上皮组织细胞角质化或皮肤粗糙,不饱和脂肪酸可以保持水代谢的平衡,保护皮肤不受x射线的损伤。氨基酸对皮肤和毛发有良好的营养作用,类黄酮具有生物兴奋作用,促进细胞代谢的功能,超氧化物歧化酶(SOD)能消除生物体在新陈代谢过程中产生的有害物质,氧自由基的自然天敌,是机体内氧自由基的头号杀手,是生命健康之本。
紫草提取物性寒,味甘、咸,归心、肝经。具有清热凉血、活血解毒、透疹消斑等功效,其含有的多种色素成分和脂肪酸具有良好的抗氧化作用,其中的紫草宁衍生物具有电子传递作用,促进或干扰某些生化反应过程,表现多种生物活性,如抗炎、免疫调节、杀菌等。
水杨酸甲酯具有局部刺激作用,可促进局部血液循环,起消肿、消炎和镇痛作用,亦有止痒之效。薄荷味辛,性凉,归肺、肝经,有发散风热,清利咽喉,透疹解毒,疏肝解郁和止痒等功效,由其提取出的薄荷脑作用于皮肤或粘膜,有清凉止痒作用;内服可作为驱风药,用于头痛及鼻;咽;喉炎症等。樟脑具有通关窍、利滞气、辟秽浊、杀虫止痒、消肿止痛的功效。丹皮酚具有镇痛、抗炎、解热和抑制变态反应的作用,冰片味辛、苦,微寒;归心、肝、肺经;清香宣散,具有开窍醒神,清热散毒,明目退翳的功效,通诸窍,散郁火,去翳明目,消肿止痛,清热散毒,散火解毒。
人体肤色变黑,主要是由于紫外线侵蚀,维生素缺乏,疾病改变正常肤色,以及洗澡时过多的揉搓和摩擦等。本申请的组合物以沙棘果油为主料,紫草提取物为辅料,同时配合水杨酸甲酯、薄荷脑、樟脑、丹皮酚和冰片作为配料,主次兼修、综合调理皮肤,使各个指标都能恢复健康。各种成分相辅相承,协同发挥作用,起到防止皮肤老化、淡化老年斑、黄褐斑,有效净化肌肤,促进细胞新陈代谢,促进上皮组织再生,防止黑色素生成,帮助皮肤抵抗紫外红侵害,使皮肤洁白无瑕;并能有效清除皮肤上堆积沉淀的色素和毒素,调节局部皮肤的微循环,拒绝垃圾减少色素、毒素沉积;众所周知,自由基是身体在新陈代谢过程中产生的一种有害物质,而本申请的上述配方在促进细胞新陈代谢的同时,其原料之间相互配合能够有效抑制自由基的成生,达到抗衰老的目的,并促使真皮层胶原细胞增生,使皮肤充盈有弹性。此外,本申请的组合物还可以用于治疗烧杀和烫伤,能迅速减轻伤者疼痛、加速伤口愈合,避免患处留下疤痕。
本申请提供的护肤膏,在上述原料的基础上添加润肤剂、增稠剂、促渗剂、抗氧化剂和紫外线吸收剂,有效促进皮肤对上述组合物的渗透和吸收,使其更好的发挥护肤作用,同时调节化妆品的性状,易于保存和涂覆。
2、本申请提供的护肤膏的制备方法中,先将沙棘果油、紫草提取物、润肤剂、增稠剂、促渗剂和紫外线吸收剂的混合物,加热至85℃,待温度降至65℃时加入丹皮酚、樟脑、薄荷脑、水杨酸甲酯、冰片和抗氧剂的混合物,在促进组成混合溶解的同时,有利于保护各成分中有效物质的活性,提高其综合性能。
具体实施方式
本申请所述的紫草提取物是以紫草全株为提取目标,以现有的任何方法进行提取得到的产品。为便于说明和比较,下述实施例中采用的紫草提取物其提取方法为取紫草粗粉20kg,于5倍体积量的乙醇水溶液(体积分数80%)中浸泡16h,再加10倍体积量的乙醇水溶液(体积分数80%)渗漉4h,接收全部渗漉,用0.45μm微孔滤膜过滤,取滤液浓缩得浸膏备用。
实施例1
本实施例的护肤膏的配方如下:
沙棘果油25kg、紫草提取物23kg、水杨酸甲酯4kg、薄荷脑2kg、樟脑2kg、丹皮酚1kg、冰片1kg,辛酸/癸酸甘油三酯20kg、聚异丁烯10kg、VP/十六碳烯共聚物4.5kg、小烛树蜡3kg、月桂氮卓酮0.5kg、生育酚3kg、甲氧基肉桂酸乙基己酯1kg。
其具体制备方法为,
(1)将沙棘果油、紫草提取物、辛酸/癸酸甘油三酯、聚异丁烯、VP/ 十六碳烯共聚物、甲氧基肉桂酸乙基己酯、月桂氮卓酮、小烛树蜡混合形成B料,备用;
(2)将生育酚、丹皮酚、樟脑、薄荷脑、水杨酸甲酯、冰片混合形成A料,加热至85℃,并保温搅拌使A料完全溶解后,开始降温,待温度降至65℃时加入所述B料,并搅拌至完全溶解后,继续搅拌降温;
(3)待降温至35℃以下时,200目滤布过滤得到滤渣,熟化制得所需的护肤膏。
实施例2
本实施例的护肤膏的配方如下:
沙棘果油20kg、紫草提取物25kg、水杨酸甲酯3.5kg、薄荷脑1.5kg、樟脑2.5kg、丹皮酚0.8kg、冰片1.5kg,辛酸/癸酸甘油三酯15kg、聚异丁烯12kg、VP/十六碳烯共聚物4kg、小烛树蜡3.5kg、月桂氮卓酮0.8kg、生育酚3.5kg、甲氧基肉桂酸乙基己酯1.2kg。
其具体制备方法为,
(1)将沙棘果油、紫草提取物、辛酸/癸酸甘油三酯、聚异丁烯、VP/十六碳烯共聚物、甲氧基肉桂酸乙基己酯、月桂氮卓酮、小烛树蜡混合形成B料,备用;
(2)将生育酚、丹皮酚、樟脑、薄荷脑、水杨酸甲酯、冰片混合形成A料,加热至85℃,并保温搅拌使A料完全溶解后,开始降温,待温度降至65℃时加入所述B料,并搅拌至完全溶解后,继续搅拌降温;
(3)待降温至35℃以下时,200目滤布过滤得到滤渣,熟化制得所需的护肤膏。
实施例3
本实施例的护肤膏的配方如下:
沙棘果油22kg、紫草提取物24kg、水杨酸甲酯4.5kg、薄荷脑2.5kg、樟脑1.5kg、丹皮酚1.2kg、冰片0.5kg,辛酸/癸酸甘油三酯18kg、聚异丁烯8kg、VP/十六碳烯共聚物5kg、小烛树蜡2.5kg、月桂氮卓酮0.7kg、生育酚3.3kg、甲氧基肉桂酸乙基己酯1.5kg。
其具体制备方法为,
(1)将沙棘果油、紫草提取物、辛酸/癸酸甘油三酯、聚异丁烯、VP/十六碳烯共聚物、甲氧基肉桂酸乙基己酯、月桂氮卓酮、小烛树蜡混合形成B料,备用;
(2)将生育酚、丹皮酚、樟脑、薄荷脑、水杨酸甲酯、冰片混合形成A料,加热至85℃,并保温搅拌使A料完全溶解后,开始降温,待温度降至65℃时加入所述B料,并搅拌至完全溶解后,继续搅拌降温;
(3)待降温至35℃以下时,200目滤布过滤得到滤渣,熟化制得所需的护肤膏。
实施例4
本实施例的护肤膏的配方如下:
沙棘果油28kg、紫草提取物22kg、水杨酸甲酯4.5kg、薄荷脑2.2kg、樟脑1.8kg、丹皮酚1.5kg、冰片0.5kg,辛酸/癸酸甘油三酯25kg、聚异丁烯11kg、VP/十六碳烯共聚物4kg、小烛树蜡2.5kg、月桂氮卓酮0.3kg、生育酚2.5kg、甲氧基肉桂酸乙基己酯0.8kg。
其具体制备方法为,
(1)将沙棘果油、紫草提取物、辛酸/癸酸甘油三酯、聚异丁烯、VP/十六碳烯共聚物、甲氧基肉桂酸乙基己酯、月桂氮卓酮、小烛树蜡混合形成B料,备用;
(2)将生育酚、丹皮酚、樟脑、薄荷脑、水杨酸甲酯、冰片混合形成A料,加热至85℃,并保温搅拌使A料完全溶解后,开始降温,待温度降至65℃时加入所述B料,并搅拌至完全溶解后,继续搅拌降温;
(3)待降温至35℃以下时,200目滤布过滤得到滤渣,熟化制得所需的护肤膏。
实施例5
本实施例的护肤膏的配方如下:
沙棘果油30kg、紫草提取物20kg、水杨酸甲酯3.5kg、薄荷脑1.6kg、樟脑2.3kg、丹皮酚0.5kg、冰片1.5kg,辛酸/癸酸甘油三酯22kg、聚异丁烯9kg、VP/十六碳烯共聚物5kg、小烛树蜡3.5kg、月桂氮卓酮0.0.1kg、生育酚2.8kg、甲氧基肉桂酸乙基己酯0.5kg。
其具体制备方法为,
(1)将沙棘果油、紫草提取物、辛酸/癸酸甘油三酯、聚异丁烯、VP/十六碳烯共聚物、甲氧基肉桂酸乙基己酯、月桂氮卓酮、小烛树蜡混合形成B料,备用;
(2)将生育酚、丹皮酚、樟脑、薄荷脑、水杨酸甲酯、冰片混合形成A料,加热至85℃,并保温搅拌使A料完全溶解后,开始降温,待温度降至65℃时加入所述B料,并搅拌至完全溶解后,继续搅拌降温;
(3)待降温至35℃以下时,200目滤布过滤得到滤渣,熟化制得所需的护肤膏。
对比例1
本对比例的护肤膏的配方如下:
沙棘果油25kg、紫草提取物23kg、冰片1kg。
其具体制备方法为,
沙棘果油、紫草提取物混合并加热至85℃,并保温搅拌使其完全溶解后,开始降温,待温度降至65℃时加入冰片,并搅拌至完全溶解后,继续搅拌降温;待降温至35℃以下时,200目滤布过滤得到滤渣,熟化制得所需的护肤膏。
对比例2
本对比例的护肤膏的配方如下:
沙棘30kg、煅珍珠母20kg、炉甘石20kg、化橘红9kg、白芨15kg、黄柏12kg、当归12kg、鸭跖草6kg、香附6kg、木香6kg、墨旱莲6kg、紫草6kg、冰片1.0kg。
将上述原料按配比粉碎成细粉过200目筛,将过筛后的细粉置于4倍体积的50℃植物油中浸泡8小时,过滤取油,冷却,得目标产品。
对比例3
本对比例的护肤膏的配方如下:
沙棘籽油60kg,紫草15kg,冰片3kg,芦荟20kg,金银花5kg。
将除了沙棘籽油和冰片以外的原料在100℃下烘干15分钟后,按照上述所示的质量混合、粉碎、过140目筛,得到粉碎细料;然后将沙棘籽油加热到85℃,加入上述粉碎细料中,得到糊状物;将糊状物放入高速匀浆机中进行匀浆,匀浆的转速为9000转/分,匀浆的时间为10分钟,得到目标产品。
评价例
安全性试验:邀请40位志愿者分为4组,分别将实施例1、对比例1、2和3的制品,涂抹于手背上,早晚各一次,重复15天,受试者未出现过敏等不适症状。
安全试验后,进行功能验证,具体方法如下:
1、袪斑性能:邀请具有日晒斑、雀斑或妊娠斑皮肤问题者40位,分成四组,分别将实施例1、对比例1、2和3的制品,涂抹于面部(避开眼部皮肤),早晚各一次,重复35天,观察受试者使用前过的面部照片,仅使用实施例1的受试者其面斑部位颜色明显变浅对比例1和3没有明显变化,对比例2的受试者其面斑部位颜色消有变浅但没有实施例1组明显。上述几组中,只有实施例1的受试者皮肤较之前自然透亮,健康洁净。
2、美白性能:邀请志愿者40位,分成四组,分别将实施例1、对比例1、2和3的制品,涂抹于手部,早晚各一次,重复35天,采用MEXAMETER MX18皮肤色素仪测定测试前及连续使用美白霜35天后其手部皮肤的黑色素含量,测试环境温度(22±1)℃,湿度(50±5)%,每组取平均值。
黑色素降低率=(使用美白霜前1天的黑色素含量-连续使用美白霜35天后黑色素含量)÷使用美白霜前1天的黑色素含量×100%。其黑色素降低率分别为15.6%(实施例1),8.5%(对比例1),2.1%(对比例2),0.2%(对比例3)。
3、改善细纹,邀请面部干燥有细纹的受试者40位,分成四组,分别将实施例1、对比例1、2和3的制品,涂抹于面部(避开眼部皮肤),早晚各一次,重复35天,观察受试者使用前过的面部照片,对比例1、2和3没有明显变化,使用实施例1的受试者面部细纹改善明显,部分细纹消失。观之仅实施例1的受试者皮肤充盈有弹性,光泽度提高。
4、改善烫伤,邀请家庭主妇40位分成四组,分别将实施例1、对比例1、2和3的制品分给上述受试者,在其日常烹饪过程中,如有油溅至皮肤上建议测试上述制品,两周后回访,其中实施例1组和对比例3组使用者反馈在使用过程中可以明显降低患者的疼痛感,创面愈合快且疤痕残留时间短。对比例1和2给使用者反馈在使用过程中疼痛感无明显降低。
显然,上述实施例仅仅是为清楚地说明所作的举例,而并非对实施方式的限定。对于所属领域的普通技术人员来说,在上述说明的基础上还可以做出其它不同形式的变化或变动。这里无需也无法对所有的实施方式予以穷举。而由此所引伸出的显而易见的变化或变动仍处于本发明创造的保护范围之中。
Claims (10)
1.一种具有美白抗衰老功效的沙棘组合物,其特征在于,包括如下重量份的组分,
沙棘果油20-30份;
紫草提取物20-25份;
水杨酸甲酯3.5-4.5份;
薄荷脑1.5-2.5份;
樟脑1.5-2.5份;
丹皮酚0.5-1.5份;
冰片0.5-1.5份。
2.根据权利要求1所述的具有美白抗衰老功效的沙棘组合物,其特征在于,包括如下重量份的组分,
沙棘果油25份;
紫草提取物23份;
水杨酸甲酯4份;
薄荷脑2份;
樟脑2份;
丹皮酚1份;
冰片1份。
3.根据权利要求1或2所述的组合物,其特征在于,以常规工艺制备形成可以接受的剂型。
4.根据权利要求3所述的组合物,其特征在于,所述剂型为外用油剂、膏剂、涂膜剂、酊剂、凝胶剂、霜或乳液。
5.一种由权利要求1-4任一所述的具有美白抗衰老功效的沙棘组合物制备形成的护肤膏,其特征在于,还包括润肤剂、增稠剂、促渗剂、抗氧化剂和紫外线吸收剂中的一种或几种。
6.根据权利要求5所述的护肤膏,其特征在于,所述润肤剂为15-25份辛酸/癸酸甘油三酯;
所述增稠剂选自聚异丁烯、VP/十六碳烯共聚物和小烛树蜡中的一种或几种,其中聚异丁烯8-12份、VP/十六碳烯共聚物4-5份、小烛树蜡2.5-3.5份;
所述促渗剂为月桂氮卓酮0.1-0.8份;
抗氧化剂为生育酚2.5-3.5份;
紫外线吸收剂甲氧基肉桂酸乙基己酯0.5-1.5份。
7.根据权利要求6所述的护肤膏,其特征在于,还包括,
辛酸/癸酸甘油三酯20份;
聚异丁烯10份、
VP/十六碳烯共聚物4.5份、
小烛树蜡3份;
月桂氮卓酮0.5份;
生育酚3份;
甲氧基肉桂酸乙基己酯1份。
8.一种制备权利要求5-7任一所述护肤膏的方法,其特征在于,
(1)称取所需重量份的丹皮酚、樟脑、薄荷脑、水杨酸甲酯、冰片和抗氧剂混合形成B料,备用;
(2)称取所需重量份的沙棘果油、紫草提取物、润肤剂、增稠剂、促渗剂和紫外线吸收剂混合形成A料,加热至85℃,并保温搅拌使A料完全溶解后,开始降温,待温度降至65℃时加入所述B料,并搅拌至完全溶解后,继续搅拌降温;
(3)待降温至35℃以下时,200目滤布过滤得到滤渣,熟化制得所需的护肤膏。
9.根据权利要求8所述的制备护肤膏的方法,其特征在于,所述步骤(3)中还包括待降温至35℃以下时,先进行检验,待检验合格后再进行过滤的步骤。
10.权利要求1-4任一所述的具有美白抗衰老功效的沙棘组合物的应用。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201611227837.5A CN106726972A (zh) | 2016-12-27 | 2016-12-27 | 一种沙棘组合物及应用和由其制备形成的护肤膏和该护肤膏的制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201611227837.5A CN106726972A (zh) | 2016-12-27 | 2016-12-27 | 一种沙棘组合物及应用和由其制备形成的护肤膏和该护肤膏的制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106726972A true CN106726972A (zh) | 2017-05-31 |
Family
ID=58921755
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201611227837.5A Pending CN106726972A (zh) | 2016-12-27 | 2016-12-27 | 一种沙棘组合物及应用和由其制备形成的护肤膏和该护肤膏的制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106726972A (zh) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107802538A (zh) * | 2017-11-29 | 2018-03-16 | 广东芭薇生物科技股份有限公司 | 一种抗衰老组合物及包含所述组合物的化妆品 |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009118104A1 (de) * | 2008-03-26 | 2009-10-01 | Bayer Materialscience Ag | Kosmetische zusammensetzungen zum auftrag auf die haut |
| CN102274154A (zh) * | 2011-09-14 | 2011-12-14 | 高小娜 | 适用于粉刺皮肤的美白防晒霜 |
| CN102836351A (zh) * | 2012-09-03 | 2012-12-26 | 皖南医学院 | 一种止痒消肿护肤精华膏及其制备方法 |
| CN103340777A (zh) * | 2013-06-21 | 2013-10-09 | 赖辉武 | 一种祛斑霜 |
| CN105534857A (zh) * | 2016-01-07 | 2016-05-04 | 江苏海昇药业有限公司 | 一种中药凝胶护肤品及其制备方法与应用 |
| WO2016144196A1 (en) * | 2015-03-07 | 2016-09-15 | Furmaniak Andrzej Karol | A pharmaceutical and/or cosmetic composition for treating skin diseases and damages, the process for preparing of the pharmaceutical and/or cosmetic composition and its use |
-
2016
- 2016-12-27 CN CN201611227837.5A patent/CN106726972A/zh active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009118104A1 (de) * | 2008-03-26 | 2009-10-01 | Bayer Materialscience Ag | Kosmetische zusammensetzungen zum auftrag auf die haut |
| CN102274154A (zh) * | 2011-09-14 | 2011-12-14 | 高小娜 | 适用于粉刺皮肤的美白防晒霜 |
| CN102836351A (zh) * | 2012-09-03 | 2012-12-26 | 皖南医学院 | 一种止痒消肿护肤精华膏及其制备方法 |
| CN103340777A (zh) * | 2013-06-21 | 2013-10-09 | 赖辉武 | 一种祛斑霜 |
| WO2016144196A1 (en) * | 2015-03-07 | 2016-09-15 | Furmaniak Andrzej Karol | A pharmaceutical and/or cosmetic composition for treating skin diseases and damages, the process for preparing of the pharmaceutical and/or cosmetic composition and its use |
| CN105534857A (zh) * | 2016-01-07 | 2016-05-04 | 江苏海昇药业有限公司 | 一种中药凝胶护肤品及其制备方法与应用 |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107802538A (zh) * | 2017-11-29 | 2018-03-16 | 广东芭薇生物科技股份有限公司 | 一种抗衰老组合物及包含所述组合物的化妆品 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105434307B (zh) | 一种含中草药提取物的祛痘膏及其制备方法 | |
| CN111202695A (zh) | 一种天然可食用的具有保健功能的组合物及其应用、彩妆化妆品及其制备方法 | |
| KR101073678B1 (ko) | 한약재를 이용한 샴푸 조성물 및 그 제조방법 | |
| CN102198066B (zh) | 一种应用于化妆品的美白祛斑剂 | |
| KR101860307B1 (ko) | 수용성 규소가 포함된 피부 보습용 화장료 조성물 | |
| CN103690434A (zh) | 一种普洱茶抗衰老霜及其制备方法 | |
| CN104814908A (zh) | 一种具有抗皱嫩肤功效的面膜 | |
| CN105560127B (zh) | 一种天然色素cc霜及其制备方法 | |
| CN103932962A (zh) | 一种中草药祛痘修复组合化妆品及其制备方法 | |
| CN108498390B (zh) | 一种治疗痤疮的藏本草提取物及其制备方法与应用 | |
| KR102086687B1 (ko) | 식물 복합추출물의 유효성분을 포함하는 피부 주름개선용 노란색 화장료 조성물 | |
| KR101735350B1 (ko) | 필란투스 니루리의 추출물 | |
| CN110433122A (zh) | 一种组合物及其在制备淡斑美白的护肤品中的应用 | |
| CN107320363A (zh) | 一种祛痘精华液 | |
| CN108066209A (zh) | 一种美白祛斑霜及其制备方法 | |
| CN110664671B (zh) | 一种植物提取物组合物及其在防晒、晒后修复、防光老化和美白化妆品中的应用 | |
| CN109010572A (zh) | 一种具有防晒增效及抗衰老作用的中药组合物及其制备方法和应用 | |
| CN109464508A (zh) | 一种修护蓝光伤害的中药组合物及其制备方法和用途 | |
| CN106137875B (zh) | 一种组合物及面膜 | |
| CN108785196A (zh) | 一种用于抚平痘坑痘印的组合物及其在化妆品中的应用 | |
| CN106726972A (zh) | 一种沙棘组合物及应用和由其制备形成的护肤膏和该护肤膏的制备方法 | |
| CN112472629A (zh) | 一种高良姜草果防晒乳液及其制备方法 | |
| CN108938511B (zh) | 天然植物提取物的组合物及在皮肤保湿祛痘产品中的应用 | |
| Adnan et al. | Phytoformulation of Sassurea lappa plant extract: A Single blind, non-invasive and split face study of cream on various skin parameters. | |
| CN118662395A (zh) | 一种用于护肤的精油组合物及其用途与制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170531 |
|
| RJ01 | Rejection of invention patent application after publication |